$11.39
0.716.59%
At close: -
$11.72
1.039.64%
Comments
Loading...
Latest KalVista Pharma Stock News | NASDAQ:KALV | Benzinga
Get the latest news on KalVista Pharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on KalVista Pharma performance
Categories: All
Monday, February 10, 2025
Friday, January 31, 2025
Tuesday, January 21, 2025
Tuesday, January 07, 2025
Tuesday, December 24, 2024
Wednesday, December 18, 2024
Monday, December 16, 2024
Monday, December 09, 2024
Friday, December 06, 2024
Thursday, December 05, 2024
Monday, November 04, 2024
Monday, October 28, 2024
Monday, October 07, 2024
Friday, October 04, 2024
Monday, September 30, 2024
Friday, September 27, 2024
Tuesday, September 10, 2024
Monday, September 09, 2024
Friday, September 06, 2024
- HC Wainwright & Co. Reiterates Buy on KalVist...
- KalVista Presented Additional Analyses Of Efficacy And Safety Of Sebetralstat From Phase 2 And Phase 3 Double-blind, Placebo-controlled Crossover Clinical Trials As Well As Interim Data From KONFIDENT-S, A Phase 3 Open-label Extension Trial
- Needham Reiterates Buy on KalVista Pharma, Ma...